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MOYAMOYA DISEASE
REPORT OF THREE CASES IN BRAZILIAN PATIENTS
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ABSTRACT - Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease of unknown etiology
reported mainly in the Japanese. Most cases occur in children. The disease is rare in non-Oriental adults manifesting
itself mostly as intracerebral hemorrhages. We describe MMD in 2 non-Oriental young adults and one adolescent
that developed cerebral infarctions. The adults were medicated with aspirin and no medication was given to the
adolescent. All patients did not deteriorate in a follow-up period from 1 to 4 years. Although rare, MMD is an
important cause of stroke in young individuals and may well be underreported: only 18 patients have been
reported till 1997 in Brazil. Neurologists should include MMD in differential diagnosis of ischemic and
hemorrhagic strokes in young adults.
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Doença de Moyamoya: relato de três pacientes brasileiros
RESUMO - A doença de moyamoya (DMM) é patologia cerebrovascular oclusiva crônica de etiologia
desconhecida, descrita inicialmente em japoneses. A maioria dos casos ocorre em crianças. Relatamos três casos
de DMM, dois adultos e um adolescente não-orientais que apresentaram a forma isquêmica da doença, embora
adultos apresentem principalmente a forma hemorrágica. Todos foram submetidos a tratamento conservador e
acompanhados durante um a quatro anos, sem piora ou recorrência dos déficits neurológicos. A DMM é uma
incomum mas importante causa de acidente vascular cerebral isquêmico, sendo subdiagnosticada em nosso país,
onde apenas 18 casos foram descritos até o 1997.
PALAVRAS-CHAVE: doença de moyamoya, adulto, doença cerebrovascular, acidente vascular cerebral.
Moyamoya disease (MMD) is a rare and chronic occlusive cerebrovascular disorder of
unknown origin mainly reported in the Japanese. Most cases occur in children1-4. Increasing numbers
of cases are now being reported in non-Japanese adults2. Characteristic angiographic findings were
first described in Japan by Takeuchi and Shimizu in 1957,4 according to Ueki et al.4. It is an unusual
but important cause of stroke2,5. Initially, it is characterized by progressive stenosis or occlusion at
the distal ends of the bilateral internal carotid arteries (ICAs) that subsequently may progress to
involve both the middle cerebral artery (MCA) and the posterior cerebral arteries3,6. An abnormal
capillary network which develops at the base of the brain and is considered as a secondary collateral
system formed as a result of progressive ischemic changes. This abnormal vascular network is
called moyamoya vessels (MV), “moyamoya’’ being a Japanese word that means “something hazy,
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like a puff of smoke drifting in the air”, describing the angiographic picture that they present3.
Usually, MMD manifests by signs and symptoms of cerebral ischemia or infarction in childhood
due to impaired circulation partially restored by collateral channels. However, adults tend to present
cerebral hemorrhages, most frequently subarachnoid haemorrhage from small arteries1-4. The
incidence of MMD occurs in two peaks: the highest one during the first decade of life, and the lower
one in the third decade3,4,7. Even in Japan, the incidence is estimated to be less than 1 in 100,000,
more commonly described in females3. In Brazil, the incidence is not known; the first description in
1981 was by Minguetti and Ferreira8 in a 3 year-old Japanese girl that developed multiple areas of
cerebral infarction. In 1997, Minelli et al.9 reported seven children and adults with MMD - cerebral
infarction in five (75%) and intracerebral haemorrhage in two (25%). The age varied from eight to
45 years-old and 83% had motor and/or language disabilities that remained.
We report herein three cases of MMD in Brazilian (non-Japanese) young men with cerebral
infarcts - a non-usual form of this disease according to reports from other countries1-4.
METHOD
From 2378 cases with diagnosis of cerebrovascular disease registered from 1992 to 1996 (all patients
aged 14 or more) in the Department of Neurology, Universidade Federal de São Paulo (UNIFESP) - Escola
Paulista de Medicina (EPM), three cases had MMD according to the Suzuki and Takaku’s angiographic
classification (conventional angiography) and diagnostic guidelines for MMD proposed by the Ministry of Health
and Welfare of Japan (MHWJ)5,10 (Tables 1 and 2). Figures 1, 2 and 3 illustrate findings.
All patients were investigated through a standard screen for young stroke patients (SSYSP) including
echocardiography, electrocardiography, chest radiography, tests for thrombophilia, autoantibodies and circulanting
lupus anticoagulant, and cardiovascular examination. SSYSP and cardiovascular examination were normal in all
patients, except in Patient 2 that had hyperlipidemia.
REPORT OF CASES
Patient 1. ARS, a 33 year-old melanodermic man presented two years previosly sudden
numbness affecting his left side of face and left arm while working. Three days later he developed
Fig 1. Contrast enhanced CT scan showing bilateral infarctions on MCA territory.
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Fig 2. Intra-arterial angiography of the right ICA showing a stenosis with occlusion of the right MCA
and stenosis of the right ACA.
Fig 3. Intra-arterial angiography of the left ICA showing severe stenosis with occlusion of the left ICA
and parenchymal collateral supply by moyamoya vessels and leptomeningeal collateral vessels.
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progressive left-sided weakness. He had smoked from the age of 19. Essential systemic arterial
hypertension was detected 2 years before the event. Upon examination he had hemiparesis, spasticity
and left sided hyperreflexia, and unmotivated laughter at tactile stimulation on paretic side. Contrast
enhanced computed tomography (CT) showed bilateral infarcts on the MCA territory, larger at
right. Magnetic resonance imaging (MRI) confirmed the extensive right sided infarct on the MCA
territory, a smaller one on the left MCA territory, and a small infarct on the right anterior cerebral
artery (ACA)territory. Intra-arterial digital subtraction cerebral angiography showed a stenosis of
the right ACA and occlusion of the right MCA, severe stenosis with distal occlusion of the left ICA,
and parenchymal collateral supply by MV and leptomeningeal collateral vessels. Findings were
classified as Suzuki and Takaku’s stage three on the right and stage two on the left. A cerebro-
meningeal biopsy showed ischemic necrosis in organization without vasculitis. He was given aspirin
- 300 mg once a day. He reported permanent left hemiparesis, unmotivated laughter disappearance
and no additional symptoms during a one year follow-up.
Patient 2. JRF, a 32 year-old Caucasian man on April/1994 developed sudden unconsciousness
with right-sided weakness. He had drinked heavily from the age of 18 until seven hours before the
event. He had essential systemic arterial hypertension. Upon examination he showed expression
aphasia, right hemiparesis with hypotonia and hyporeflexia. CT showed an infarct on the left MCA
territory. MRI was not performed. Intra-arterial conventional cerebral angiography showed occlusion
of the left ICA at the supraclinoidal portion and of the left MCA, with MV around. Suzuki and
Takaku’s classification: two/three on the left. A 300 mg dose of aspirin, to be taken once a day, was
prescribed. In february/1995 he had two seizures and was given antiepileptic drugs with success.
Upon review, he reported persistence of hemiparesis, improvement of speech disorder, and no new
neurological symptoms during a follow-up period of two years.
Patient 3. RAM, a 14 year-old previously healthy Caucasian boy. In february/1992, during
physical exercise, he developed a severe right-sided headache, speech disturbance and left- sided
weakness. These symptoms disappeared hours later, but headache persisted. Eight days later he
Table 1. Angiographic classification (according to Suzuki and Takaku (1969).
Stage 1. stenosis of the carotid artery at its suprasellar portion, usually bilateral.
Stage 2. moyamoya vessels begin to develop at the base of the brain.
Stage 3. moyamoya vessels become more prominent as major trunks in the anterior circulation become
severely stenotic or occluded.
Stage 4. posterior cerebral arteries are occluded, moyamoya vessels begin to diminish and collateral pathways
from extracranial circulation develop.
Stage 5. moyamoya vessels are diminishing and extracranial circulation progresses.
Stage 6. moyamoya vessels and the major cerebral arteries completely disappear, the cerebral hemispheres
receive blood through the abnormal extracranial-intracranial anastomosis.
Table 2. Diagnostic guidelines for MMD according to MHWJ.
1. Stenosis or occlusion of the intracranial internal carotid artery or the adjacent anterior and middle cerebral
arteries.
2. Abnormal vascular network adjacent to the stenosed artery identified during the arterial phase of
angiography.
3. Bilateral findings on angiography.
4. No other identifiable cause.
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awoke with speech disturbance and weakness on the left arm and leg. Upon examination he had a
mild left hemiparesis and dysarthria. CT showed infarct in the bilateral MCA territory, which was
more extensive on the right. Intra-arterial conventional cerebral angiography showed occlusion of
the right ICA at the supraclinoid portion with MMV around and stenosis of the left intracranial ICA.
Suzuki and Takaku’s classification: stage two on the right and stage one on the left. He was not
given any drug, yet his speech became normal and he had motor improvement on the right. No new
neurological symptoms have been noted during a follow-up period of four years.
DISCUSSION
More than 40 years after MMD was recognized, it remains an intriguing illness. The etiology,
natural history, pathogenesis and ideal treatment have been poorly defined1,4,12,13. This uncertainty is
partly due to the absence of long-term follow-up12. There seems to be no relation to risk factors such
as hypertension, diabetes or hyperlipidaemia2. We detected hypertension in two patients and
hyperlipidemia in one, however we do not know if they are associated or co-existent conditions.
Angiographic appearance of an abnormal vascular network at the base of the brain (moyamoya
vessels) associated to identifiable cause is known as moyamoya syndrome1,14,15.
The disease does not evidence arteritis, intimal thickening or medial thinning of the affected
carotid arteries in histologic studies2-4,7. Bacterial infections have been associated with MMD2. Suzuki
and Kodama in 1983 speculated that inflammation of the extensive sympathetic innervation of the
ICAs may be responsible for these localized changes since there was clinical improvement with
perivascular sympathectomy in some patients2.
Typically, MMD starts in the first decade with complete stroke or recurring transient ischemic
attacks -TIA- (sometimes induced by crying, coughing or straining) that cause motor, sensory, visual
and speech disturbances, seizures, chorea and personality changes1-4,12. In adults, MMD is rare and
70 to 80% of patients develop bleeding in the basal ganglia, thalamus, or ventricles due to rupture of
the fragile abnormal vessels. In non-Japanese adults MMD is rare, specially when presenting with
cerebral infarction (described in 30 to 42% of the adults)1. Our patients were non-Japanese men
aged 14 years or more that presented the “ischemic form” of MMD with TIA and/or infarctions in
carotid territories. In Patient 3, the hyperventilation during exercise that caused precipitation of
symptoms could represent critical perfusion in an area near infarction (right MCA territory).
CT and MRI can visualize intracranial changes in patients with MMD: multiple dilated abnormal
vessels at the basal ganglia or thalamus (or both), narrowing or occlusion of major arteries of the circle
of Willis, ischemic infarctions predominantly in watershed areas and hemorrhages1,6,11. In our patients,
CT and/or MRI showed infarcts in the ACM territory in all and infarct in ACA territory in one, with
centrum semiovale and basal ganglia affected in severe proportions. Infarctions in adults with MMD
tend to occur in the watershed regions between anterior, middle, and posterior cerebral arteries circulation,
mainly in the centrum semiovale and basal ganglia that are in a more vulnerable region supplied by
long, penetrating branches of ACA and ACM. This might be explained by age-associated change in the
capacity to form collateral pathways between basal perforating vessels and medullar arteries arising
from ACA and ACM. Also, lenticulostriate arteries (some of the most important vessels among basal
MV) become smaller in number and size with advancing age1,2.
In a study of 518 patients reported by Nishimoto in 1979, the mortality rate was higher in adults
(10%) than in children (4.3%), in whom the intracranial bleeding was the main cause of death4.
Treatment remains unsatisfactory because the pathophysiology of MMD is still not unclarified.
Conservative measures as vasodilators, steroids, anticoagulants and antibiotics have been used and
considered ineffective2,4. However, cases with satisfactory follow-up, with non-surgical treatment
were described, mostly in adults3. A surgical procedure for revascularization of the ischemic brain
by creating collateral pathways has been considered the most reasonable treatment, especially for
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children with ischemic symptoms. Surgical results including synangiosis, for which a muscle flap with
its own established network of vessels is applied to the dural surface, and extracranial-intracranial
bypass operations, for which isolated vessels are used, have showed a beneficial effect in some cases2,4.
Our patients received conservative treatment. Two have taken 300 mg of aspirin a day, and
their motor disabilities have improved without any deterioration over a follow-up period from one
to four years. In Brazil, only 18 patients with MMD have been described up to 19979, but the disease
may well be underdiagnosed.
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